4//SEC Filing
Yi Qingqing 4
Accession 0000902664-22-003398
CIK 0001651308other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:15 PM ET
Size
8.1 KB
Accession
0000902664-22-003398
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Ordinary Shares
2022-06-22+16,692→ 24,492 total - Award
Share Option (Right to Buy)
2022-06-22−34,645→ 34,645 totalExercise: $11.98Exp: 2032-06-21→ Ordinary Shares (34,645 underlying)
Footnotes (3)
- [F1]Represents securities underlying RSUs. All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
- [F3]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
Documents
Issuer
BeiGene, Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001662556
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:15 PM ET
- Size
- 8.1 KB